Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Atherosclerosis × Atorvastatin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Prostatic Neoplasms 9 Neoplasms 4 Endometrial Neoplasms 3 Colonic Neoplasms 3 Cardiotoxicity 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Heart Failure 2 Glioblastoma 2 Endometrial Hyperplasia 2 Colorectal Neoplasms 2 Cardiovascular Diseases 2 Venous Thrombosis 1 Smoking 1 Pulmonary Disease, Chronic Obstructive 1 Precancerous Conditions 1 Overall Survival 1 Ototoxicity 1 Neoplastic Cells, Circulating 1 Neoplasms, Plasma Cell 1 Nasopharyngeal Carcinoma 1 Melanoma 1

Interventions

Exercise 2 evolocumab 1 Standard of Care 1 Rosuvastatin Calcium 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Blood Specimen Collection 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06785974 2025-01-22

SPIRAL

Erasmus Medical Center

Phase 4 Not yet recruiting

Melanoma, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡